CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.
暂无分享,去创建一个
[1] Young Kon Kim,et al. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤ 2.0 cm) in patients with hepatitis-induced liver cirrhosis , 2013, Acta radiologica.
[2] Elaine M. Caoili,et al. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. , 2013, Radiology.
[3] M. Reiser,et al. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate , 2012, Acta radiologica.
[4] Rajagopal N. Aravalli,et al. Cellular and molecular mechanisms of hepatocellular carcinoma: an update , 2012, Archives of Toxicology.
[5] N. Hosten,et al. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. , 2012, Radiology.
[6] B. Corcioni,et al. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: Hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd‐EOB‐DTPA administration , 2012, Journal of magnetic resonance imaging : JMRI.
[7] R. Brody,et al. An inflammatory proposal for hepatocarcinogenesis , 2012, Hepatology.
[8] W. Palmer,et al. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.
[9] J. Bruix,et al. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. , 2012, Journal of hepatology.
[10] E. Brunt,et al. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. , 2012, Journal of hepatology.
[11] A. Tanimoto,et al. Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[12] R. Vaughan,et al. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. , 2012, Human Pathology.
[13] N. Rofsky,et al. Hepatobiliary MR imaging with gadolinium‐based contrast agents , 2012, Journal of magnetic resonance imaging : JMRI.
[14] T. Tamada,et al. Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver. , 2011, European journal of radiology.
[15] M. Sherman,et al. Indeterminate 1‐2‐cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none? , 2011, Hepatology.
[16] N. Toyota,et al. Clinical Significance of the Transitional Phase at Gadoxetate Disodium–Enhanced Hepatic MRI for the Diagnosis of Hepatocellular Carcinoma: Preliminary Results , 2011, Journal of computer assisted tomography.
[17] Osamu Matsui,et al. Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression , 2011, European Radiology.
[18] C. Verslype,et al. Molecular classification of hepatocellular carcinoma anno 2011. , 2011, European journal of cancer.
[19] H. El‐Serag,et al. Risk factors for cholangiocarcinoma , 2011, Hepatology.
[20] M. Fiorentino,et al. OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation , 2011, Virchows Archiv.
[21] Y. N. Park. Update on precursor and early lesions of hepatocellular carcinomas. , 2011, Archives of pathology & laboratory medicine.
[22] O. Matsui,et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging , 2011, European Radiology.
[23] K. McGlynn,et al. The global epidemiology of hepatocellular carcinoma: present and future. , 2011, Clinics in liver disease.
[24] R. Gish,et al. Hepatocellular carcinoma: molecular and genomic guideline for the clinician. , 2011, Clinics in liver disease.
[25] N. Nishida,et al. Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review , 2011, Current genomics.
[26] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[27] O. Matsui,et al. Effect of change in transporter expression on gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging during hepatocarcinogenesis in rats , 2011, Journal of gastroenterology and hepatology.
[28] Myeong-Jin Kim,et al. Hepatocarcinogenesis: imaging-pathologic correlation , 2011, Abdominal Imaging.
[29] C. Bartolozzi,et al. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR , 2011, Abdominal Imaging.
[30] O. Matsui,et al. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging. , 2010, Radiology.
[31] Osamu Matsui,et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. , 2010, Radiology.
[32] Yuan Ji,et al. Contribution of Diffusion-Weighted Magnetic Resonance Imaging in the Characterization of Hepatocellular Carcinomas and Dysplastic Nodules in Cirrhotic Liver , 2010, Journal of computer assisted tomography.
[33] Jessica Zucman-Rossi,et al. Molecular classification of hepatocellular carcinoma. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[34] M. Kudo. Real Practice of Hepatocellular Carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress , 2010, Oncology.
[35] Tonsok Kim,et al. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. , 2010, Radiology.
[36] Masahiro Okada,et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow , 2010, European Radiology.
[37] K. Suh,et al. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[38] J. Marrero,et al. Recent advances in the treatment of hepatocellular carcinoma , 2010, Current opinion in gastroenterology.
[39] Jeong Min Lee,et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma , 2010, Hepatology international.
[40] R. Freeman,et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[41] P. Robinson,et al. Enhancement of liver parenchyma after injection of hepatocyte‐specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumine , 2010, Journal of magnetic resonance imaging : JMRI.
[42] T. Roskams,et al. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. , 2010, Seminars in liver disease.
[43] K. Hegenscheid,et al. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol. , 2009, AJR. American journal of roentgenology.
[44] T. Murakami,et al. Consensus report of the 2nd International Forum for Liver MRI , 2009, European Radiology.
[45] C. Loddenkemper,et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. , 2009, AJR. American journal of roentgenology.
[46] J. Bruix,et al. Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma , 2009, Hepatology.
[47] O. Matsui,et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. , 2009, Radiology.
[48] Y. Maehara,et al. Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: A Histological Assessment of 365 Patients in Japan , 2009, Annals of Surgical Oncology.
[49] J. Marrero,et al. Modern diagnosis and management of hepatocellular carcinoma. , 2009, Clinics in liver disease.
[50] X. Hao,et al. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. , 2009, Surgical oncology.
[51] H. Honda,et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. , 2009, Radiology.
[52] Michiie Sakamoto,et al. Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.
[53] Y. Maehara,et al. Extracapsular Penetration is a New Prognostic Factor in Human Hepatocellular Carcinoma , 2008, The American journal of surgical pathology.
[54] D. Mitchell,et al. Single breath‐hold multiarterial dynamic MRI of the liver at 3T using a 3D fat‐suppressed keyhole technique , 2008, Journal of magnetic resonance imaging : JMRI.
[55] F. Trevisani,et al. Recent advances in the natural history of hepatocellular carcinoma. , 2008, Carcinogenesis.
[56] J. Willatt,et al. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. , 2008, Radiology.
[57] D. Aguirre,et al. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[58] J. Bruix,et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.
[59] M. Sakamoto. Pathology of early hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[60] K. Gurusamy. Trace Element Concentration in Primary Liver Cancers—A Systematic Review , 2007, Biological Trace Element Research.
[61] H. Honda,et al. Poorly Versus Moderately Differentiated Hepatocellular Carcinoma: Vascularity Assessment by Computed Tomographic Hepatic Angiography in Correlation With Histologically Counted Number of Unpaired Arteries , 2007, Journal of computer assisted tomography.
[62] Derek Y. Chiang,et al. Genomics and signaling pathways in hepatocellular carcinoma. , 2007, Seminars in liver disease.
[63] K. Jhaveri,et al. Value of the Unenhanced Phase for Detection of Hepatocellular Carcinomas 3 cm or Less When Performing Multiphase Computed Tomography in Patients With Cirrhosis , 2007, Journal of computer assisted tomography.
[64] Lorella Pascolo,et al. Molecular Determinants in the Transport of a Bile Acid-Derived Diagnostic Agent in Tumoral and Nontumoral Cell Lines of Human Liver , 2006, Journal of Pharmacology and Experimental Therapeutics.
[65] E. Lesaffre,et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.
[66] Myeong-Jin Kim,et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. , 2006, AJR. American journal of roentgenology.
[67] Katsuyoshi Ito. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. , 2006, European journal of radiology.
[68] Won J. Lee,et al. Encapsulated hepatocellular carcinoma: CT-pathologic correlations , 2006, European Radiology.
[69] Yoshiyuki Suzuki,et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis , 2006, Cancer.
[70] J. Mintorovitch,et al. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.
[71] J. Bruix,et al. Management of hepatocellular carcinoma , 2005, Hepatology.
[72] Maximilian F Reiser,et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. , 2005, Radiology.
[73] Carlo Catalano,et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. , 2005, Radiology.
[74] M. Kojiro,et al. Histopathology of liver cancers. , 2005, Best practice & research. Clinical gastroenterology.
[75] K. McGlynn,et al. Epidemiology and natural history of hepatocellular carcinoma. , 2005, Best practice & research. Clinical gastroenterology.
[76] G. Krinsky,et al. Iron‐containing nodules of cirrhosis , 2004, NMR in biomedicine.
[77] T. Murakami,et al. Multidetector Row CT and MR Imaging in Diagnosing Hepatocellular Carcinoma , 2004, Intervirology.
[78] Josep Fuster,et al. The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[79] K. McGlynn,et al. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.
[80] W. Jarnagin,et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. , 2003, Journal of the American College of Surgeons.
[81] W. Coleman,et al. Mechanisms of human hepatocarcinogenesis. , 2003, Current molecular medicine.
[82] Masatoshi Tanaka,et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[83] U. Schmiedl,et al. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre–liver transplant patients: radiologic–histopathologic correlation of explanted livers , 2003, Abdominal Imaging.
[84] G. Israel,et al. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. , 2003, AJR. American journal of roentgenology.
[85] H. Ueno,et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features , 2002, Cancer.
[86] O. Matsui,et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. , 2002, Radiology.
[87] Hiroto Nakajima,et al. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? , 2002, AJR. American journal of roentgenology.
[88] S. Thorgeirsson,et al. Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.
[89] T. Yamanaka,et al. Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called 'dysplastic nodule-carcinoma' sequence? , 2002, Oncology reports.
[90] J. H. Lim,et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. , 2002, AJR. American journal of roentgenology.
[91] V. Lorusso,et al. Pharmacokinetics and Safety of Gadobenate Dimeglumine (Multihance) in Subjects With Impaired Liver Function , 2002, Investigative radiology.
[92] K. Takeshita,et al. Effect of Superparamagnetic Iron Oxide-Enhanced MRI of the Liver With Hepatocellular Carcinoma and Hyperplastic Nodule , 2002, Journal of computer assisted tomography.
[93] B. I. Choi,et al. Dysplastic nodules in liver cirrhosis: imaging , 2002, Abdominal Imaging.
[94] L. Donoso,et al. Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis. , 2002, Seminars in ultrasound, CT, and MR.
[95] M S Peterson,et al. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.
[96] T. Roskams,et al. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non‐cirrhotic and cirrhotic chronic viral hepatitis , 2001, Histopathology.
[97] G. Jacobs,et al. An early lesion in hepatic carcinogenesis: Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36‐p34 region , 2001, Hepatology.
[98] M. Uemura,et al. The formation of capsule and septum in human hepatocellular carcinoma , 2001, Virchows Archiv.
[99] M. Nalesnik,et al. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. , 2000, AJR. American journal of roentgenology.
[100] N. Rofsky,et al. Siderotic Nodules at MR Imaging: Regenerative or Dysplastic? , 2000, Journal of computer assisted tomography.
[101] M. Kojiro,et al. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. , 2000, Journal of hepatology.
[102] J. Svensson,et al. Image artifacts due to a time‐varying contrast medium concentration in 3D contrast‐enhanced MRA , 1999, Journal of magnetic resonance imaging : JMRI.
[103] H. Honda,et al. Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. , 1999, AJR. American journal of roentgenology.
[104] K. Ohtomo,et al. Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: Results from phase II and phase III clinical trials in Japan , 1999, Journal of magnetic resonance imaging : JMRI.
[105] D. Mitchell,et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. , 1999, Radiology.
[106] S. Swan,et al. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. , 1999, Investigative radiology.
[107] R. Manfredi,et al. Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis , 1998, Journal of magnetic resonance imaging : JMRI.
[108] Y. N. Park,et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. , 1998, The American journal of surgical pathology.
[109] T. Nabika,et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver , 1998, Hepatology.
[110] K. Okuda. Hepatocellular carcinoma: Clinicopathological aspects , 1997, Journal of gastroenterology and hepatology.
[111] N. Rofsky,et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. , 1996, Radiology.
[112] N. Theise. Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. , 1996, Gastroenterology.
[113] K. Batts,et al. Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. , 1996, Journal of computer assisted tomography.
[114] N. Theise,et al. Macroregenerative (Dysplastic) Nodules and Hepatocarcinogenesis: Theoretical and Clinical Considerations , 1995, Seminars in liver disease.
[115] I. Wanless,et al. Terminology of nodular hepatocellular lesions , 1995 .
[116] M. Sentís,et al. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. , 1995, Radiology.
[117] T. Aihara,et al. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. , 1994, Gastroenterology.
[118] M. Kanematsu,et al. Extracapsular Invasion of Small Hepatocellular Carcinoma: MR and CT Findings , 1994, Journal of computer assisted tomography.
[119] M. Kojiro,et al. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells , 1993, Hepatology.
[120] T. Murakami,et al. CT and MRI of Siderotic Regenerating Nodules in Hepatic Cirrhosis , 1992, Journal of computer assisted tomography.
[121] S. Fan,et al. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases , 1992, Cancer.
[122] O. Matsui,et al. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. , 1992, Radiology.
[123] K. Shirabe,et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses , 1991, Hepatology.
[124] M. Makuuchi,et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma , 1990, The Lancet.
[125] T. Terada,et al. Iron‐accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies , 1990, Cancer.
[126] M. Kojiro,et al. Hepatocellular carcinoma presenting as intrabile duct tumor growth. A clinicopathologic study of 24 cases , 1982, Cancer.
[127] Lu-Yu Hwang,et al. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.
[128] H. Edmondson,et al. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.
[129] V. Mazzaferro,et al. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, European journal of cancer.
[130] Jun Cui,et al. Small intestinal vascular malformation bleeding: diagnosis by double-balloon enteroscopy combined with abdominal contrast-enhanced CT examination , 2011, Abdominal Imaging.
[131] E. Merkle,et al. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. , 2010, AJR. American journal of roentgenology.
[132] O. Nakashima,et al. Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins , 1995, Hepatology.
[133] T. Roskams,et al. Early hepatocellular carcinoma and dysplastic nodules. , 2005, Seminars in liver disease.
[134] A. Ba-Ssalamah,et al. Multidetektor-CT (MDCT) der Leber , 2004, Der Radiologe.
[135] T. Murakami,et al. Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. , 2002, Archives of surgery.
[136] O. Matsui,et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. , 1998, Radiology.
[137] N M Rofsky,et al. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. , 1997, Radiology.
[138] T. Winter,et al. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. , 1995, AJR. American journal of roentgenology.